Ledger.Open graph →
SEC Form D · filed March 27, 2024

CND Life Sciences, Inc

Offering
$6.0M
Sold
$2.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SCOTTSDALE, AZ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Enrique J. Carrazana · Coral Gables, FLDirectorPeter J. Harris · Brookline, MADirectorRichard J. Morello · Atlanta, GAExec · DirectorTodd J. Levine · Paradise Valley, AZExec · DirectorRobert Hartog · Denver, CODirectorAlex Appleton · London, United KingdomDirectorMatthew Shaw · London, United KingdomExec · DirectorHaakon Overli · London, United KingdomExec · DirectorTodd Sachse · Detroit, MIExec · DirectorMerredith Treaster · San Francisco, CADirectorCheryl R. Zabala · New York, NYExec · DirectorAlexander M. Liang, M.D · Dallas, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗